-
Mirabegron CAS 223673-61-8Mirabegron CAS 223673-61-8, is a beta-3 adrenergic receptor agonist used for treatment of overactive bladder.read more
Indications: overactive bladder, urinary frequency, urgency. -
Etravirine CAS 269055-15-4Etravirine CAS 269055-15-4, is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It is...read more
-
Favipiravir CAS 259793-96-9Favipiravir CAS 259793-96-9, is a broad-spectrum antiviral agent that selectively inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. It is a pyrazinecarboxamide derivative with a...read more
-
Ilaprazole Base CAS 172152-36-2Ilaprazole Base CAS 172152-36-2, is a proton pump inhibitor (PPI) used for treatment of gastric acid-related disorders.read more
Indications: gastric ulcer, duodenal ulcer, reflux esophagitis -
Vonoprazan Fumarate CAS 1260141-27-2Vonoprazan Fumarate CAS 1260141-27-2, is a new type of oral potassium-competitive acid blocker that inhibits gastric acid secretion by competitively inhibiting H⁺, K⁺-ATPase (proton pump) in...read more
-
Daridorexant Hcl CAS 1792993-84-0Daridorexant Hcl CAS 1792993-84-0, is a new type of oral dual orexin receptor antagonist (DORA) that helps patients fall asleep and maintain sleep by blocking the binding of the wake-promoting...read more
-
Lemborexant CAS 1369764-02-2Lemborexant CAS 1369764-02-2, is a Sleep Initiation and Maintenance Disorders drug used for treatment of adult insomnia characterized by difficulty falling asleep and/or maintaining sleep.read more
-
Trelagliptin Succinate CAS 1029877-94-8Trelagliptin Succinate CAS 1029877-94-8, is a dipeptidyl peptidase-4 (DPP-4) inhibitor, treatment of Type 2 Diabetes.read more
-
Vericiguat CAS 1350653-20-1Vericiguat CAS 1350653-20-1, is a soluble guanylate cyclase (sGC) stimulator, treatment of Heart Failure.read more
Mirabegron is used alone or in combination with solifenacin (Vesicare) to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination,...
May 20, 2022 · hives or welts, skin rash. indigestion. itching or pain of the vagina or genital area. pain or tenderness around the eyes and cheekbones. pressure in the stomach. redness of the...
Mirabegron is an orally bioavailable agonist of the human beta-3 adrenergic receptor (ADRB3), with muscle relaxing, neuroprotective and potential antineoplastic activities. Upon oral administration,...
Mirabegron controla los síntomas de la vejiga hiperactiva o la hiperactividad del detrusor neurogénico, pero no cura estas afecciones. Puede tomar 8 semanas o más antes de que...
Myrbetriq (mirabegron) may cause unusual swelling likely due to an allergic reaction (angioedema), which can make it hard to breathe. This can happen right after taking the first dose, or after...
Jul 17, 2021 · Mirabegron is a medication used in the management of overactive bladder. It is in the sympathomimetic class of medications. This activity...
